APA (7th ed.) Citation

Weiß, J., Bajraktari-Sylejmani, G., & Haefeli, W. E. (2021). Low risk of the TMPRSS2 inhibitor camostat mesylate and its metabolite GBPA to act as perpetrators of drug-drug interactions. Chemico-biological interactions, 338, . https://doi.org/10.1016/j.cbi.2021.109428

Chicago Style (17th ed.) Citation

Weiß, Johanna, Gzona Bajraktari-Sylejmani, and Walter E. Haefeli. "Low Risk of the TMPRSS2 Inhibitor Camostat Mesylate and Its Metabolite GBPA to Act as Perpetrators of Drug-drug Interactions." Chemico-biological Interactions 338 (2021). https://doi.org/10.1016/j.cbi.2021.109428.

MLA (9th ed.) Citation

Weiß, Johanna, et al. "Low Risk of the TMPRSS2 Inhibitor Camostat Mesylate and Its Metabolite GBPA to Act as Perpetrators of Drug-drug Interactions." Chemico-biological Interactions, vol. 338, 2021, https://doi.org/10.1016/j.cbi.2021.109428.